期刊文献+

甲状腺功能亢进症糖代谢紊乱机制的研究进展 被引量:16

下载PDF
导出
摘要 甲状腺功能亢进症(简称甲亢)是以甲状腺激素(TH)分泌过多引起的一种临床综合征。甲亢患者常伴有不同程度的糖代谢紊乱,如糖耐量减低(IGT)甚至糖尿病。目前,对于甲状腺功能亢进症糖代谢紊乱的机制尚未完全明了,各家报道不一,主要有超生理量甲状腺激素的作用、胰岛素的抵抗(IR)、胰岛β功能的损害。
出处 《医学文选》 2006年第3期518-520,共3页 Anthology of Medicine
  • 相关文献

参考文献19

  • 1Prager C,Cross HS,Peterlik M.Triiodothyronine stimulstes 2-deoxy-D-glucose uptake by organ cultured embryonic chick small intestine[J].Acta-Endocrinol(copenh),1990,122(5):585~591
  • 2Bhattachaiyya A,Wiles PG.Diabetic Ketocidosis precitated by thyrotoxicosis[J].Postgrad Med J,1999,75(883):291~292
  • 3刘宏.200例甲状腺功能亢进症糖耐量结果分析[J].青海医药杂志,1997,27(6):13-14.
  • 4Lavill M,Riou JP,Bougneres PF et al.Glucose metabolism in experimental hyperthyroidism:intact in vivo sensitivity to insulin with abnormal binding and increased glucose turnover[J].J Clin Endocrinol Metab,1984,58(6):960~965
  • 5Mokuno T,Uchimura K,Hayashi R,et al.Glucose transporter 2concentrations in hyper-and hypothyroid rat livers[J].J Endocrinol,1999,160(2):285~289
  • 6Bech K,Damsbo P.Eldrup E,et al.Beta-cell function and glucose and lipid oxidation in Graves disease[J].Clinical Endocrinol (Oxf),1996,44(1):59~66
  • 7Voldstedlund M,Tranum-Jensen J,Handberg A,et al.Quantity of Na/K-ATPase and glucose transporters in the plasma membrane of rat adipocytes is reduced by in vivo triiodothyronine[J].Eur J Endocrinol,1995,133(5):626~634
  • 8白耀主编.甲状腺基础与临床[M].北京:科学技术文献出版社,2003:101~103
  • 9Tosi F,Moghetti P,Castello R,et al.Early changes in plasma glucagons and growth hormone response to oral glucose in experimental hyperthyroidism[J].Metabolism,1996,45(8):1029~ 1033
  • 10刘薇,袁申元,王雪,潘素芳,于湄,谢荣荣.Graves病患者胰岛素、真胰岛素变化与糖耐量的关系[J].首都医科大学学报,2004,25(1):78-81. 被引量:1

二级参考文献17

  • 1李昌臣 童钟杭 江蓓.内分泌代谢系统疾病的实验室检查与临床应用及其再评价[J].中国实用内科杂志,1999,8:451-458.
  • 2Mykkanen L, Haffner S M, Hales C N, et al. The relation of proinsulin, insulin, and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in nomoglycemic subjects. Diabetes, 1997,46:1990~1995
  • 3Pestell R, Alford F, Ramos R, et al. Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in thyrotoxicosis: a minimal model analysis. Clin Endocrinol, 1990,33:481~483
  • 4Yamada T, Shirota T, Aizawa T, et al. Blood glucose, serum thyroid hormones, insulin, C-peptide and C-peptide/insulin ratio in hyperthyroid patients. Hormone Meta Res, 1991,23:504~505
  • 5Bech K, Damsbo P, Eldrup E, et al. Beta-cell function and lipid oxidation in Graves' disease. Clin Endocrinol Oxf, 1996,44(1):59~66
  • 6Custro N, Scafidi V, Costanza G, et al. Insulin resistance in patients with Graves' disease and reduced glucose tolerance. The normalization of fasting insulin secretion in parallel with the restoration of thyroid function. Minerva Med, 1990,81(7):523~527
  • 7Ohguni S, Notsu K, Kato Y. Correlation of plasma free thyroxine levels with insulin sensitivity and metabolic clearance rate of insulin in patients with hyperthyroid Graves' disease. Intern Med, 1995,34(5):339~341
  • 8Komiya L, Yamada T, Sato A, et al. Effects of antithyroid drug therapy on blood glucose, serum insulin, and insulin binding to red blood cells in hyperthyroid patients of different ages. Diabetes Care, 1985,8(2):161~168
  • 9GonzaloMA,GrantC,MorenoI,etal.Glucosetolerance,insu linsecretion ,insulinsensitivityandglucoseeffectivenessinnormalandoverweighthyperthyroidwomen〔J〕[].ClinEndocrinol(Oxf).1996
  • 10Casla A,Arrieta F,Grnat C,et al.Effect of short-and longterm experimental hyperthyroidism on plasma glucose level and insulin secretion during an intravenous glucose load and on insulin binding, insulin receptor kinase activity and insulin action in adipose tissue〔J〕[].Metabolism.1993

共引文献23

同被引文献52

引证文献16

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部